Literature DB >> 17473578

Is the activated partial thromboplastin time suitable to screen for von Willebrand factor deficiencies?

Giuseppe Lippi1, Massimo Franchini, Giovanni Poli, Gian Luca Salvagno, Martina Montagnana, Gian Cesare Guidi.   

Abstract

The diagnostic approach to von Willebrand factor deficiencies is challenging and requires discretionary use of laboratory resources. Although extensive preoperative testing is not recommended, the activated partial thromboplastin time may be useful, especially in selected categories of patients. To establish the diagnostic sensitivity of this test to identify isolate von Willebrand factor deficiencies, 204 consecutive patients underwent a routine preoperative screening consisting of activated partial thromboplastin time, von Willebrand factor antigen, intrinsic pathway clotting factors activity, lupus anticoagulants and thrombin time. Thirty-seven patients were diagnosed with haemostasis disturbances other than von Willebrand factor deficiencies and were excluded from the evaluation. Isolated von Willebrand factor deficiency was diagnosed in 11 of the remaining 167 patients. A significant correlation was observed between von Willebrand factor antigen and activated partial thromboplastin time. Receiver operating characteristic curve analysis showed an area under the curve of 0.982 (95% confidence interval: 0.972-0.992; P < 0.001). At the 1.17 upper limit of the activated partial thromboplastin time, sensitivity and specificity were 100 and 85%, respectively, with negative and positive predictive values of 100 and 31%, respectively. These results demonstrate that activated partial thromboplastin time has an excellent diagnostic sensitivity and a satisfactory specificity for identifying isolated von Willebrand factor deficiencies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17473578     DOI: 10.1097/MBC.0b013e32810fd872

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  4 in total

1.  Higher morning serum cortisol level predicts increased fibrinogen but not shortened APTT.

Authors:  Giuseppe Lippi; Massimo Franchini; Gian Luca Salvagno; Martina Montagnana; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2007-07-13       Impact factor: 2.300

2.  Clinical relevance of isolated prolongation of the activated partial thromboplastin time in a cohort of adults undergoing surgical procedures.

Authors:  Giuseppe Tagariello; Paolo Radossi; Roberta Salviato; Milena Zardo; Lucia De Valentin; Marco Basso; Giancarlo Castaman
Journal:  Blood Transfus       Date:  2016-07-22       Impact factor: 3.443

3.  A genetic association study of activated partial thromboplastin time in European Americans and African Americans: the ARIC Study.

Authors:  Lu-Chen Weng; Mary Cushman; James S Pankow; Saonli Basu; Eric Boerwinkle; Aaron R Folsom; Weihong Tang
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

4.  Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study.

Authors:  Christina Ellervik; Samia Mora; Aleksander Kuś; Bjørn Åsvold; Eirini Marouli; Panos Deloukas; Rosalie B T M Sterenborg; Alexander Teumer; Stephen Burgess; Maria Sabater-Lleal; Jennifer Huffman; Andrew D Johnson; David-Alexandre Trégouet; Nicolas L Smith; Marco Medici; Paul S DeVries; Daniel I Chasman; Alisa D Kjaergaard
Journal:  Thyroid       Date:  2021-08-05       Impact factor: 6.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.